Know Cancer

or
forgot password

    • cancer clinical trials in burlington, VT

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lung Cancer
    SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lymphoma
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Head and Neck Cancer
    Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
    Fletcher-Allen Health Care
    Burlington, Vermont 05401
    Head and Neck Cancer
    Surgery in Treating Patients With Prostate Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Prostate Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Sarcoma
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    STI571 in Treating Patients With Recurrent Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Prostate Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lymphoma
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Head and Neck Cancer
    Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia, Lymphoma
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Prostate Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Kidney Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Metastatic Cancer, Prostate Cancer
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Breast Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Kidney Cancer
    Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Prostate Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Colorectal Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Fletcher Allen Health Care-Medical Center
    Burlington, Vermont 05401
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Multiple Myeloma and Plasma Cell Neoplasm
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Radiation Therapy in Treating Young Patients With Gliomas
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Fletcher Allen Health Care-Medical Center
    Burlington, Vermont 05401
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Colorectal Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia
    Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Breast Cancer
    Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Kidney Cancer
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Esophageal Cancer
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Cervical Cancer, Endometrial Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Prostate Cancer